Skip to main content
. 2021 Dec 11;94(4):1558–1565. doi: 10.1002/jmv.27500

Table 1.

Comparison of laboratory parameters in the study population

Variables Mild disease (mean ± SD) Severe disease (mean ± SD) Healthy controls (mean ± SD) p value
Age (years) 36 ± 8.4 37.8 ± 8.2 35 ± 8.7 0.18
Male 30 (50%) 38 (63%) 31 (52%)
Female 30 (50%) 22 (37%) 29 (48%)
Fever 26.7% 81.7 0 <0.001
Cough 13.3% 60% 0 0.01
Fatigue 45% 55% 0 0.15
Myalgia 13.3% 23.3% 0 0.10
Diarrhea 8.3% 25% 0 0.06
Shortness of breath 8% 43.3% 0 <0.001
WBC (/µl) 8230 ± 840 11600 ± 2630 5920 ± 1030 <0.001
RBC (/µl) 4.9 * 106 ± 0.3 4.6 * 106 ± 0.4 4.9 * 106 ± 0.3 0.71
Neutrophils (%) 68.7 ± 7 82 ± 6.8 68 ± 6.2 <0.001
Lymphocytes (%) 30.3 ± 6.7 15 ± 6.9 30.6 ± 6.3 <0.001
NLR (%) 2.43 ± 0.81 8.3 ± 7.2 2.36 ± 0.76 <0.001
ESR 26 ± 6.7 69 ± 30 5.75 ± 3.1 <0.001
CRP (mg/l) 7.7 ± 1.3 89 ± 40 2.5 ± 0.97 <0.001
Hb (g/dl) 13.01 ± 1 12.7 ± 1.3 13.1 ± 1.4 0.24
HCT (%) 39.4 ± 2.8 38.6 ± 4.3 39.6 ± 4.4 0.31
PLT (/µl) 279 * 103 ± 37 210 * 103 ± 42 258 * 103 ± 40 0.05
PH 7.34 ± 0.01 7.37 ± 0.02 7.34 ± 0.01 0.06
PO2 (mmHg) 88.1 ± 4.5 59.4 ± 10 90.2 ± 5.5 <0.001
PCO2 (mmHg) 40.2 ± 3 52.4 ± 14 39.5 ± 2.8 0.05
SaO2 (%) 93.4 ± 1.3 66.7 ± 14.5 97 ± 1.4 0.01
Na (meq/l) 138 ± 5 138 ± 4.5 140 ± 3.4 0.64
K (meq/l) 4.3 ± 0.43 3.9 ± 0.3 4 ± 0.37 0.53
Ca (mg/dl) 9 ± 0.5 8.6 ± 0.5 9.3 ± 0.4 0.01
BS (mg/dl) 85 ± 11 100 ± 30 84 ± 5.8 0.96
BUN (mg/dl) 31 ± 7 35 ± 14 26 ± 6.8 0.71
Cr (mg/dl) 0.9 ± 0.2 0.9 ± 0.26 0.85 ± 0.34 0.34
AST (u/l) 25 ± 8 35 ± 11 22 ± 8.3 0.21
ALT (u/l) 26 ± 8 32 ± 10 25 ± 8.5 0.62
LDH (u/l) 297 ± 53 500 ± 300 244 ± 42 0.05
PT (second) 13 ± 0.28 14 ± 1.4 12.8 ± 0.36 0.65
PTT (second) 31 ± 4 35 ± 9 30 ± 4.3 0.61

Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; CRP, c‐reactive protein; ESR, erythrocyte sedimentation rate; HCT, hematocrit; LDH, lactate dehydrogenase; NLR, neutrophil‐lymphocyte ratio; PLT, platelet; PT, prothrombin time; PTT, partial thromboplastin time.